FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Biologics Day 2

OTP Town Hall: Gene Therapy Manufacturing CMC & Facility Readiness for BLAs & Post-licensure Changes

FDA’s Rare Disease Day 2026 – An Event for Patients

FDA Regulatory Education for Industry (REdI) – Devices Track

FDA Expert Panel on Testosterone Replacement Therapy for Men

CMC - NDA requirements and Common Pitfalls of BLAs (14of15) REdI – May 29-30, 2019

FDA Roundtable on Cell and Gene Therapy

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

How is My Medical Device Classified?

FDA Regulatory Education for Industry (REdI) – Biologics Track

FDA Direct: Combating Rare Diseases at the FDA

REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2)

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

OTC Monograph Reform: OTC Sunscreen Drugs

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

Postmarketing Adverse Drug Experience (PADE) Inspections – (1of3) Jun. 19, 2018

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Plenary + Drugs Day 1